about
Dimeric peroxiredoxins are druggable targets in human Burkitt lymphoma.Low dose of GRP78-targeting subtilase cytotoxin improves the efficacy of photodynamic therapy in vivo.Investigation of cell death mechanisms in human lymphatic endothelial cells undergoing photodynamic therapy.HDAC6 inhibition upregulates CD20 levels and increases the efficacy of anti-CD20 monoclonal antibodies.Inhibition of autophagy sensitizes cancer cells to Photofrin-based photodynamic therapy.Targeting peroxiredoxin 1 impairs growth of breast cancer cells and potently sensitises these cells to prooxidant agentsTypical and Atypical Inducers of Lysosomal Cell Death: A Promising Anticancer StrategyInhibition of thioredoxin-dependent HO removal sensitizes malignant B-cells to pharmacological ascorbate
P50
Q36738950-F457459A-0D55-4EA4-8CBE-E995FF10D6D2Q36915065-2DA752F1-E4CC-4EB0-8512-739D2D7A695FQ38794930-96B09438-FFE3-4DEF-BDD3-8115EF7BE8CCQ47767233-520F4E18-11B1-429D-B426-B42EC8586FE0Q49796148-38895A4C-2299-41D0-9BDD-442790CA8154Q56978909-8A46658F-FD60-405B-A522-4944F7FF5BD9Q58804941-9F412420-B6B3-4C2C-B45E-9F0962E006A9Q60310884-180512DF-FE8C-44CD-8924-205B039F59B0
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Antoni Domagala
@en
Antoni Domagala
@nl
type
label
Antoni Domagala
@en
Antoni Domagala
@nl
prefLabel
Antoni Domagala
@en
Antoni Domagala
@nl
P31
P496
0000-0002-4753-2026